BIOREM Inc. BIRMF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 128.09% | -59.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 128.09% | -59.11% | |||
| Cost of Revenue | 96.89% | -49.88% | |||
| Gross Profit | 249.64% | -76.19% | |||
| SG&A Expenses | 77.53% | -42.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 94.20% | -48.52% | |||
| Operating Income | 1,344.69% | -95.12% | |||
| Income Before Tax | 882.25% | -92.51% | |||
| Income Tax Expenses | 900.39% | -91.15% | |||
| Earnings from Continuing Operations | 875.20% | -92.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 875.20% | -92.89% | |||
| EBIT | 1,344.69% | -95.12% | |||
| EBITDA | 903.48% | -92.87% | |||
| EPS Basic | 870.33% | -93.44% | |||
| Normalized Basic EPS | 875.32% | -93.08% | |||
| EPS Diluted | 848.75% | -93.58% | |||
| Normalized Diluted EPS | 851.47% | -93.12% | |||
| Average Basic Shares Outstanding | 0.44% | 8.49% | |||
| Average Diluted Shares Outstanding | 2.72% | 9.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||